Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Stat3 has the capacity to mediate IL-6- and IL-11-dependent IEC survival and to promote proliferation through G1 and G2/M cell-cycle progression as the common tumor cell-autonomous mechanism that bridges chronic inflammation to tumor promotion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP913975.RAY-R16fkpV5DX3UaCJpKhfmyfnRqOWmPBdVuik0MVWzw130_assertion description "[Stat3 has the capacity to mediate IL-6- and IL-11-dependent IEC survival and to promote proliferation through G1 and G2/M cell-cycle progression as the common tumor cell-autonomous mechanism that bridges chronic inflammation to tumor promotion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP913975.RAY-R16fkpV5DX3UaCJpKhfmyfnRqOWmPBdVuik0MVWzw130_provenance.
• NP861794.RA2kVCxnDB5yPJb-mm3tL2gztImmYzqCdx4Tusq4RjtZg130_assertion description "[Stat3 has the capacity to mediate IL-6- and IL-11-dependent IEC survival and to promote proliferation through G1 and G2/M cell-cycle progression as the common tumor cell-autonomous mechanism that bridges chronic inflammation to tumor promotion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP861794.RA2kVCxnDB5yPJb-mm3tL2gztImmYzqCdx4Tusq4RjtZg130_provenance.
• NP505635.RAXu9uzMzX28KIbQQIiPUCmL3LRmrncsmjEY2kBd5dgxA130_assertion description "[Stat3 has the capacity to mediate IL-6- and IL-11-dependent IEC survival and to promote proliferation through G1 and G2/M cell-cycle progression as the common tumor cell-autonomous mechanism that bridges chronic inflammation to tumor promotion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP505635.RAXu9uzMzX28KIbQQIiPUCmL3LRmrncsmjEY2kBd5dgxA130_provenance.
• NP499575.RAXEljL8AF92R0xSvgRF6x0n4TmYtxbe26G0meGIG9UJ4130_assertion description "[Stat3 has the capacity to mediate IL-6- and IL-11-dependent IEC survival and to promote proliferation through G1 and G2/M cell-cycle progression as the common tumor cell-autonomous mechanism that bridges chronic inflammation to tumor promotion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP499575.RAXEljL8AF92R0xSvgRF6x0n4TmYtxbe26G0meGIG9UJ4130_provenance.
• assertion description "[Stat3 has the capacity to mediate IL-6- and IL-11-dependent IEC survival and to promote proliferation through G1 and G2/M cell-cycle progression as the common tumor cell-autonomous mechanism that bridges chronic inflammation to tumor promotion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Stat3 has the capacity to mediate IL-6- and IL-11-dependent IEC survival and to promote proliferation through G1 and G2/M cell-cycle progression as the common tumor cell-autonomous mechanism that bridges chronic inflammation to tumor promotion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Stat3 has the capacity to mediate IL-6- and IL-11-dependent IEC survival and to promote proliferation through G1 and G2/M cell-cycle progression as the common tumor cell-autonomous mechanism that bridges chronic inflammation to tumor promotion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP717940.RABeGq-NqTuh1XjN0rR66DKY3hZ0ye4lwMuI0uCcASsGw130_assertion description "[Stat3 has the capacity to mediate IL-6- and IL-11-dependent IEC survival and to promote proliferation through G1 and G2/M cell-cycle progression as the common tumor cell-autonomous mechanism that bridges chronic inflammation to tumor promotion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP717940.RABeGq-NqTuh1XjN0rR66DKY3hZ0ye4lwMuI0uCcASsGw130_provenance.
• NP717116.RAmPOacK97xjlz4RdgNpE-TGwMd5MVPAXICF6orC3q3h0130_assertion description "[Stat3 has the capacity to mediate IL-6- and IL-11-dependent IEC survival and to promote proliferation through G1 and G2/M cell-cycle progression as the common tumor cell-autonomous mechanism that bridges chronic inflammation to tumor promotion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP717116.RAmPOacK97xjlz4RdgNpE-TGwMd5MVPAXICF6orC3q3h0130_provenance.
• NP505638.RAkf753buc34YCeYoRdPiRRhT5_uhT6487Eo0gq58O84c130_assertion description "[Stat3 has the capacity to mediate IL-6- and IL-11-dependent IEC survival and to promote proliferation through G1 and G2/M cell-cycle progression as the common tumor cell-autonomous mechanism that bridges chronic inflammation to tumor promotion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP505638.RAkf753buc34YCeYoRdPiRRhT5_uhT6487Eo0gq58O84c130_provenance.
• NP717941.RAoMUXNHUSoPSB3abT2G6z7RqRQa7SYgP3WIQqCeOLxB4130_assertion description "[Stat3 has the capacity to mediate IL-6- and IL-11-dependent IEC survival and to promote proliferation through G1 and G2/M cell-cycle progression as the common tumor cell-autonomous mechanism that bridges chronic inflammation to tumor promotion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP717941.RAoMUXNHUSoPSB3abT2G6z7RqRQa7SYgP3WIQqCeOLxB4130_provenance.
• NP499519.RA7AeMLMOC3PuE-LAg7LVRl9sVHk0j9Mz7h6O9wwV2Wn8130_assertion description "[Stat3 has the capacity to mediate IL-6- and IL-11-dependent IEC survival and to promote proliferation through G1 and G2/M cell-cycle progression as the common tumor cell-autonomous mechanism that bridges chronic inflammation to tumor promotion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP499519.RA7AeMLMOC3PuE-LAg7LVRl9sVHk0j9Mz7h6O9wwV2Wn8130_provenance.
• NP717076.RA3rdDBz8rbNnYXSlq279yQ5klkxlwwikpWACqoSJJ3CU130_assertion description "[Stat3 has the capacity to mediate IL-6- and IL-11-dependent IEC survival and to promote proliferation through G1 and G2/M cell-cycle progression as the common tumor cell-autonomous mechanism that bridges chronic inflammation to tumor promotion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP717076.RA3rdDBz8rbNnYXSlq279yQ5klkxlwwikpWACqoSJJ3CU130_provenance.
• NP717938.RAN7S4BNfPvJiqDYp30y4MOKw6a-CyzH1axgLRN1zZzgA130_assertion description "[Stat3 has the capacity to mediate IL-6- and IL-11-dependent IEC survival and to promote proliferation through G1 and G2/M cell-cycle progression as the common tumor cell-autonomous mechanism that bridges chronic inflammation to tumor promotion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP717938.RAN7S4BNfPvJiqDYp30y4MOKw6a-CyzH1axgLRN1zZzgA130_provenance.